APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chickenpox (Varicella) Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Chickenpox (Varicella) Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025180 pages

Choose your research edition.

Industry ResearchChickenpox (Varicella) Vaccine Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Chickenpox (Varicella) Vaccine Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Chickenpox (Varicella) Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chickenpox (Varicella) Vaccine Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Chickenpox (Varicella) Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Chickenpox (Varicella) Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Chickenpox (Varicella) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chickenpox (Varicella) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chickenpox (Varicella) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Chickenpox (Varicella) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Chickenpox (Varicella) Vaccine include Shanghai Institute, Merck & Co., GSK, Sanofi Pasteur, Keygen, Green Cross, Changsheng, Biken and BCHT, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Chickenpox (Varicella) Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chickenpox (Varicella) Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chickenpox (Varicella) Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Chickenpox (Varicella) Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Chickenpox (Varicella) Vaccine Segment by Company

Shanghai Institute

Merck & Co.

GSK

Sanofi Pasteur

Keygen

Green Cross

Changsheng

Biken

BCHT

Chickenpox (Varicella) Vaccine Segment by Type

Monovalent Vaccine

Combination Vaccine

Chickenpox (Varicella) Vaccine Segment by Application

Kids Injection

Adults Injection

Chickenpox (Varicella) Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chickenpox (Varicella) Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chickenpox (Varicella) Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chickenpox (Varicella) Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Chickenpox (Varicella) Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Chickenpox (Varicella) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Chickenpox (Varicella) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Chickenpox (Varicella) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Chickenpox (Varicella) Vaccine Industry Trends Table 2. Chickenpox (Varicella) Vaccine Industry Drivers Table 3. Chickenpox (Varicella) Vaccine Industry Opportunities and Challenges Table 4. Chickenpox (Varicella) Vaccine Industry Restraints Table 5. Global Chickenpox (Varicella) Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Chickenpox (Varicella) Vaccine Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Chickenpox (Varicella) Vaccine Sales Market Share by Manufacturers Table 9. Global Chickenpox (Varicella) Vaccine Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Chickenpox (Varicella) Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Chickenpox (Varicella) Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Chickenpox (Varicella) Vaccine Manufacturers, Product Type & Application Table 13. Global Chickenpox (Varicella) Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Chickenpox (Varicella) Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Monovalent Vaccine Table 17. Major Manufacturers of Combination Vaccine Table 18. Global Chickenpox (Varicella) Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Chickenpox (Varicella) Vaccine Sales by Type (2021-2026) & (k units) Table 20. Global Chickenpox (Varicella) Vaccine Sales by Type (2027-2032) & (k units) Table 21. Global Chickenpox (Varicella) Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Chickenpox (Varicella) Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Chickenpox (Varicella) Vaccine Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Chickenpox (Varicella) Vaccine Revenue by Type (2021-2026) & (k units) Table 25. Global Chickenpox (Varicella) Vaccine Revenue by Type (2027-2032) & (k units) Table 26. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Kids Injection Table 29. Major Manufacturers of Adults Injection Table 30. Global Chickenpox (Varicella) Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Chickenpox (Varicella) Vaccine Sales by Application (2021-2026) & (k units) Table 32. Global Chickenpox (Varicella) Vaccine Sales by Application (2027-2032) & (k units) Table 33. Global Chickenpox (Varicella) Vaccine Sales Market Share by Application (2021-2026) Table 34. Global Chickenpox (Varicella) Vaccine Sales Market Share by Application (2027-2032) Table 35. Global Chickenpox (Varicella) Vaccine Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Chickenpox (Varicella) Vaccine Revenue by Application (2021-2026) & (k units) Table 37. Global Chickenpox (Varicella) Vaccine Revenue by Application (2027-2032) & (k units) Table 38. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Application (2027-2032) Table 40. Global Chickenpox (Varicella) Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Chickenpox (Varicella) Vaccine Sales by Region (2021-2026) & (k units) Table 42. Global Chickenpox (Varicella) Vaccine Sales Market Share by Region (2021-2026) Table 43. Global Chickenpox (Varicella) Vaccine Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Chickenpox (Varicella) Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Chickenpox (Varicella) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Chickenpox (Varicella) Vaccine Sales by Country (2021-2026) & (k units) Table 47. North America Chickenpox (Varicella) Vaccine Sales by Country (2027-2032) & (k units) Table 48. Europe Chickenpox (Varicella) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Chickenpox (Varicella) Vaccine Sales by Country (2021-2026) & (k units) Table 50. Europe Chickenpox (Varicella) Vaccine Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Chickenpox (Varicella) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Chickenpox (Varicella) Vaccine Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Chickenpox (Varicella) Vaccine Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Chickenpox (Varicella) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Country (2027-2032) & (k units) Table 57. Global Chickenpox (Varicella) Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Chickenpox (Varicella) Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Chickenpox (Varicella) Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Region (2021-2026) Table 61. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Region (2027-2032) Table 62. Shanghai Institute Company Information Table 63. Shanghai Institute Business Overview Table 64. Shanghai Institute Chickenpox (Varicella) Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Shanghai Institute Chickenpox (Varicella) Vaccine Product Portfolio Table 66. Shanghai Institute Recent Development Table 67. Merck & Co. Company Information Table 68. Merck & Co. Business Overview Table 69. Merck & Co. Chickenpox (Varicella) Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Merck & Co. Chickenpox (Varicella) Vaccine Product Portfolio Table 71. Merck & Co. Recent Development Table 72. GSK Company Information Table 73. GSK Business Overview Table 74. GSK Chickenpox (Varicella) Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. GSK Chickenpox (Varicella) Vaccine Product Portfolio Table 76. GSK Recent Development Table 77. Sanofi Pasteur Company Information Table 78. Sanofi Pasteur Business Overview Table 79. Sanofi Pasteur Chickenpox (Varicella) Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Sanofi Pasteur Chickenpox (Varicella) Vaccine Product Portfolio Table 81. Sanofi Pasteur Recent Development Table 82. Keygen Company Information Table 83. Keygen Business Overview Table 84. Keygen Chickenpox (Varicella) Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Keygen Chickenpox (Varicella) Vaccine Product Portfolio Table 86. Keygen Recent Development Table 87. Green Cross Company Information Table 88. Green Cross Business Overview Table 89. Green Cross Chickenpox (Varicella) Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Green Cross Chickenpox (Varicella) Vaccine Product Portfolio Table 91. Green Cross Recent Development Table 92. Changsheng Company Information Table 93. Changsheng Business Overview Table 94. Changsheng Chickenpox (Varicella) Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Changsheng Chickenpox (Varicella) Vaccine Product Portfolio Table 96. Changsheng Recent Development Table 97. Biken Company Information Table 98. Biken Business Overview Table 99. Biken Chickenpox (Varicella) Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Biken Chickenpox (Varicella) Vaccine Product Portfolio Table 101. Biken Recent Development Table 102. BCHT Company Information Table 103. BCHT Business Overview Table 104. BCHT Chickenpox (Varicella) Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. BCHT Chickenpox (Varicella) Vaccine Product Portfolio Table 106. BCHT Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Chickenpox (Varicella) Vaccine Distributors List Table 110. Chickenpox (Varicella) Vaccine Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Chickenpox (Varicella) Vaccine Product Image Figure 2. Global Chickenpox (Varicella) Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chickenpox (Varicella) Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Chickenpox (Varicella) Vaccine Sales (2021-2032) & (k units) Figure 5. Global Chickenpox (Varicella) Vaccine Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Chickenpox (Varicella) Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Monovalent Vaccine Image Figure 9. Combination Vaccine Image Figure 10. Global Chickenpox (Varicella) Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Chickenpox (Varicella) Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Chickenpox (Varicella) Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Chickenpox (Varicella) Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Chickenpox (Varicella) Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Kids Injection Image Figure 17. Adults Injection Image Figure 18. Global Chickenpox (Varicella) Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Chickenpox (Varicella) Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Chickenpox (Varicella) Vaccine Sales Market Share by Application (2021-2032) Figure 21. Global Chickenpox (Varicella) Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Chickenpox (Varicella) Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America Chickenpox (Varicella) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Chickenpox (Varicella) Vaccine Sales Market Share by Country (2021-2032) Figure 26. U.S. Chickenpox (Varicella) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Chickenpox (Varicella) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Chickenpox (Varicella) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Chickenpox (Varicella) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Chickenpox (Varicella) Vaccine Sales Market Share by Country (2021-2032) Figure 31. Germany Chickenpox (Varicella) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Chickenpox (Varicella) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Chickenpox (Varicella) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Chickenpox (Varicella) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Chickenpox (Varicella) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Chickenpox (Varicella) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Chickenpox (Varicella) Vaccine Sales Market Share by Country (2021-2032) Figure 38. China Chickenpox (Varicella) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Chickenpox (Varicella) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Chickenpox (Varicella) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Chickenpox (Varicella) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Chickenpox (Varicella) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Chickenpox (Varicella) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Chickenpox (Varicella) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Chickenpox (Varicella) Vaccine Sales Market Share by Country (2021-2032) Figure 46. Brazil Chickenpox (Varicella) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Chickenpox (Varicella) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Chickenpox (Varicella) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Chickenpox (Varicella) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Chickenpox (Varicella) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Chickenpox (Varicella) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Chickenpox (Varicella) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Chickenpox (Varicella) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Chickenpox (Varicella) Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Figure 57. North America Chickenpox (Varicella) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Chickenpox (Varicella) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Chickenpox (Varicella) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Chickenpox (Varicella) Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Chickenpox (Varicella) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Chickenpox (Varicella) Vaccine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Chickenpox (Varicella) Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Monovalent Vaccine
  • Combination Vaccine
Applications
  • Kids Injection
  • Adults Injection
Companies covered
  • Shanghai Institute
  • Merck & Co.
  • GSK
  • Sanofi Pasteur
  • Keygen
  • Green Cross
  • Changsheng
  • Biken
  • BCHT

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Chickenpox (Varicella) Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Chickenpox (Varicella) Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Chickenpox (Varicella) Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Chickenpox (Varicella) Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Chickenpox (Varicella) Vaccine Market Dynamics
  1. 2.1 Chickenpox (Varicella) Vaccine Industry Trends
  2. 2.2 Chickenpox (Varicella) Vaccine Industry Drivers
  3. 2.3 Chickenpox (Varicella) Vaccine Industry Opportunities and Challenges
  4. 2.4 Chickenpox (Varicella) Vaccine Industry Restraints
3 Chickenpox (Varicella) Vaccine Market by Manufacturers
  1. 3.1 Global Chickenpox (Varicella) Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Chickenpox (Varicella) Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Chickenpox (Varicella) Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Chickenpox (Varicella) Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Chickenpox (Varicella) Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Chickenpox (Varicella) Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Chickenpox (Varicella) Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Chickenpox (Varicella) Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Chickenpox (Varicella) Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Chickenpox (Varicella) Vaccine Tier 1, Tier 2, and Tier 3
4 Chickenpox (Varicella) Vaccine Market by Type
  1. 4.1 Chickenpox (Varicella) Vaccine Type Introduction
  2. 4.1.1 Monovalent Vaccine
  3. 4.1.2 Combination Vaccine
  4. 4.2 Global Chickenpox (Varicella) Vaccine Sales by Type
  5. 4.2.1 Global Chickenpox (Varicella) Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Chickenpox (Varicella) Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Chickenpox (Varicella) Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Chickenpox (Varicella) Vaccine Revenue by Type
  9. 4.3.1 Global Chickenpox (Varicella) Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Chickenpox (Varicella) Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Chickenpox (Varicella) Vaccine Revenue Market Share by Type (2021-2032)
5 Chickenpox (Varicella) Vaccine Market by Application
  1. 5.1 Chickenpox (Varicella) Vaccine Application Introduction
  2. 5.1.1 Kids Injection
  3. 5.1.2 Adults Injection
  4. 5.2 Global Chickenpox (Varicella) Vaccine Sales by Application
  5. 5.2.1 Global Chickenpox (Varicella) Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Chickenpox (Varicella) Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Chickenpox (Varicella) Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Chickenpox (Varicella) Vaccine Revenue by Application
  9. 5.3.1 Global Chickenpox (Varicella) Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Chickenpox (Varicella) Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Chickenpox (Varicella) Vaccine Revenue Market Share by Application (2021-2032)
6 Global Chickenpox (Varicella) Vaccine Sales by Region
  1. 6.1 Global Chickenpox (Varicella) Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Chickenpox (Varicella) Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Chickenpox (Varicella) Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Chickenpox (Varicella) Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Chickenpox (Varicella) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Chickenpox (Varicella) Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Chickenpox (Varicella) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Chickenpox (Varicella) Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Chickenpox (Varicella) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Chickenpox (Varicella) Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Chickenpox (Varicella) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Chickenpox (Varicella) Vaccine Revenue by Region
  1. 7.1 Global Chickenpox (Varicella) Vaccine Revenue by Region
  2. 7.1.1 Global Chickenpox (Varicella) Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Chickenpox (Varicella) Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Chickenpox (Varicella) Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Chickenpox (Varicella) Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Chickenpox (Varicella) Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Chickenpox (Varicella) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Chickenpox (Varicella) Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Chickenpox (Varicella) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Chickenpox (Varicella) Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Chickenpox (Varicella) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Chickenpox (Varicella) Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Chickenpox (Varicella) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Shanghai Institute
  2. 8.1.1 Shanghai Institute Company Information
  3. 8.1.2 Shanghai Institute Business Overview
  4. 8.1.3 Shanghai Institute Chickenpox (Varicella) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Shanghai Institute Chickenpox (Varicella) Vaccine Product Portfolio
  6. 8.1.5 Shanghai Institute Recent Developments
  7. 8.2 Merck & Co.
  8. 8.2.1 Merck & Co. Company Information
  9. 8.2.2 Merck & Co. Business Overview
  10. 8.2.3 Merck & Co. Chickenpox (Varicella) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck & Co. Chickenpox (Varicella) Vaccine Product Portfolio
  12. 8.2.5 Merck & Co. Recent Developments
  13. 8.3 GSK
  14. 8.3.1 GSK Company Information
  15. 8.3.2 GSK Business Overview
  16. 8.3.3 GSK Chickenpox (Varicella) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GSK Chickenpox (Varicella) Vaccine Product Portfolio
  18. 8.3.5 GSK Recent Developments
  19. 8.4 Sanofi Pasteur
  20. 8.4.1 Sanofi Pasteur Company Information
  21. 8.4.2 Sanofi Pasteur Business Overview
  22. 8.4.3 Sanofi Pasteur Chickenpox (Varicella) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sanofi Pasteur Chickenpox (Varicella) Vaccine Product Portfolio
  24. 8.4.5 Sanofi Pasteur Recent Developments
  25. 8.5 Keygen
  26. 8.5.1 Keygen Company Information
  27. 8.5.2 Keygen Business Overview
  28. 8.5.3 Keygen Chickenpox (Varicella) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Keygen Chickenpox (Varicella) Vaccine Product Portfolio
  30. 8.5.5 Keygen Recent Developments
  31. 8.6 Green Cross
  32. 8.6.1 Green Cross Company Information
  33. 8.6.2 Green Cross Business Overview
  34. 8.6.3 Green Cross Chickenpox (Varicella) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Green Cross Chickenpox (Varicella) Vaccine Product Portfolio
  36. 8.6.5 Green Cross Recent Developments
  37. 8.7 Changsheng
  38. 8.7.1 Changsheng Company Information
  39. 8.7.2 Changsheng Business Overview
  40. 8.7.3 Changsheng Chickenpox (Varicella) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Changsheng Chickenpox (Varicella) Vaccine Product Portfolio
  42. 8.7.5 Changsheng Recent Developments
  43. 8.8 Biken
  44. 8.8.1 Biken Company Information
  45. 8.8.2 Biken Business Overview
  46. 8.8.3 Biken Chickenpox (Varicella) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Biken Chickenpox (Varicella) Vaccine Product Portfolio
  48. 8.8.5 Biken Recent Developments
  49. 8.9 BCHT
  50. 8.9.1 BCHT Company Information
  51. 8.9.2 BCHT Business Overview
  52. 8.9.3 BCHT Chickenpox (Varicella) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 BCHT Chickenpox (Varicella) Vaccine Product Portfolio
  54. 8.9.5 BCHT Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Chickenpox (Varicella) Vaccine Value Chain Analysis
  2. 9.1.1 Chickenpox (Varicella) Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Chickenpox (Varicella) Vaccine Production Mode & Process
  6. 9.2 Chickenpox (Varicella) Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Chickenpox (Varicella) Vaccine Distributors
  9. 9.2.3 Chickenpox (Varicella) Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst